Table 4 Unadjusted and adjusted analysis to assess adverse fetal and neonatal outcomes (Quantitative) associated with GWG
From: The impact of gestational weight gain on fetal and neonatal outcomes: the Araraquara Cohort Study
Outcomes | Gestacional weight gain (IOM-2019) | |||
|---|---|---|---|---|
Below | Above | Below | Above | |
β (IC95%) | β (IC95%) | β adj (IC95%) | β adj (IC95%) | |
Abdominal subcutaneous tissue thickness (TSA) | -0.02 (-0.10-0.06) | 0.01 (-0.06-0.09) | -0.00 (-0.06-0.06) | 0.05 (-0.00-0.11) |
Arm subcutaneous tissue area (TSB) | -0.14 (-0.35-0.07) | 0.06 (-0.15–0.27) | -7.99 (-8.97–7.02) | -0.08 (-0.17-0.01) |
Thigh subcutaneous tissue área (TSC) | -0.55 (-1.04 - -0.06) | -0.16 (-0.62–0.31) | -0.25 (-0.45–0.05) | -0.01 (-0.20-0.19) |
% Fat mass (%FM) | -0.28 (-0.76-0.20) | 2.52 (2.09–2.95) | -0.85 (-1.12–0.58) | 1.21 (0.94–1.48) |
% Fat-free mass (%FFM) | 1.51 (0.09–2.94) | 0.87 (-0.41-2.15) | 1.05 (-0.39-2.49) | 0.52 (-0.86-1.91) |
Birth length | -0.79 (-1.07–0.51) | -0.22 (-0.56-0.12) | -0.76 (-1.03–0.49) | -0.26 (-0.60-0.08) |
Fetal weight | -62.9 (-136.4–10.6) | -39.8 (-112.1–32.5) | -17.73 (-38.07-2.61 | 7.50 (-13.03-28.04) |
Birth weight | -175.2 (-214.2–136.3) | 98.5 (61.5-135.4) | -189.30 (-227.9–150.7) | 90.14 (53.3–127) |